Transpupillary thermotherapy for central serous chorioretinopathy with parafoveal leaks
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [30]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    AIM:To explore the clinical effect of transpupillary thermotherapy(TTT)for the treatment of central serous chorioretinopathy(CSC)with parafoveal leaks.

    METHODS: Twenty-three eyes from nineteen patients with long-standing CSC and parafoveal leaks(50-200μm around the fovea)who opted for TTT and observation were enrolled in this study. Eighteen of nineteen patients(23 eyes)were male, fourteen of twenty-three eyes were right eyes. The patients' mean age was 44.00±4.973 years(range from 32-52 years). TTT was performed using 810nm infrared diode laser. All patients underwent Snellen visual acuity measurement(converted to LogMAR for analysis)fundus examination, fluorescein angiography(FFA)and optical coherence tomography(OCT). Follow-up was scheduled at 1, 2, 6mo.

    RESULTS:Following treatment of TTT, complete resolution of neurosensory detachment on OCT and disappearance of leakage on FFA was seen in fourteen eyes(61%), twenty-one eyes(91%)at the 2mo and twenty-three eyes(100%)at the 6mo respectively. A total of 74% had ≥3 lines of improvement after 6mo. Success was defined as resolution of neurosensory on OCT and disappearance of leakage on FFA at the 2mo. Failure was defined as no change at the 6mo and no improvement of visual acuity.

    CONCLUSION:TTT is safe and effective therapeutic option in patients with CSC and parafoveal leaks. It may improve the visual acuity by shortening the persistent serous elevation of the macula.

    Reference
    1 Maruko I.Evaluation of the choroid in central serous chorioretinopathy. Nihon Ganka Gakkai 2012; 116(11):1062-1079
    2 Karakus SH,Basarir B,Pinarci EY, et al. Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes. Eye(Lond) 2013; 27(5):612-620
    3 Smretschnig E,Ansari-Shahrezaei S,Hagen S, et al. Half-fluence photodynamic therapy in chronic central serous chorioretinopathy. Retina 2013; 33(2):316-323
    4 Jamil AZ, Rahman FU, Iqbal K, et al. Intravitreal bevacizumab in central serous chorioretinopathy. J Coll Physicians Surg Pak 2012; 22(6):363-366
    5 Mazzolani F, Togni S. Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy:a 12-month follow-up study. Clin Ophthalmol 2013; 7:939-945
    6 Casella AM,Berbel RF,Bressanim GL, et al. Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy. Clinics(Sao Paulo) 2012; 67(9):1047-1052
    7 Quin G, Liew G, Ho IV, et al. Diagnosis and interventions for central serous chorioretinopathy: review and update. Clin Experiment Ophthalmol 2013; 41(2):187-200
    8 Shukla D, Kolluru C, Vignesh TP, et al.Transpupillary thermotherapy for subfoveal leaks in central serous Chorioretinopathy. Eye(Lond) 2008; 22(1):100-106
    9 Hussain N, Khanna R, Hussain A, et al. Transpupillary thermotherapy for chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2006; 244(8):1045-1051
    10 Manayath GJ,Narendran V,Arora S, et al. Graded subthreshold transpupillary thermotherapy for chronic central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging 2012; 43(4):284-290
    11 Gemenetzi M,De Salvo G,Lotery AJ.Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye(Lond) 2010; 24(12):1743-1756
    12 Spitznas M, Huke J. Number, shape and topography of leakage points in acute type I central serous retinopathy. Graefes Arch Clin Exp Ophthalmol 1987; 225(6):437-440
    13 Reche-Frutos J,Calvo-González C,Donate-López J, et al. Photodynamic therapy in severe chronic central serous chorioretinopaty. Arch Soc Esp Oftalmo 2008; 83(1):9-14
    14 Chan WM, Lai TY, Lai RY, et al. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy one-year results of a randomized controlled trial. Ophthalmology 2008; 115(10):1756-1765
    15 Li L, Yuan F, Xu GZ, et al. Photodynamic therapy for treatment of chronic or recurrent central serous chorioretinopathy. Zhonghua Yan Ke Za Zhi 2012; 48(2):106-113
    16 Maruko I,Iida T,Sugano Y, et al. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 2010; 117(9):1792-1799
    17 Lai TY, Chan WM, Li H, et al. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol 2006; 90(7):869-874
    18 Chan WM, Lai TY, Lai RY, et al. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 2008; 28(1):85-93
    19 Torres-Soriano ME, García-Aguirre G, Kon-Jara V, et al. A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2008; 246(9):1235-1239
    20 Nicholson B,Noble J,Forooghian F, et al. Central serous chorioretinopathy:update on pathophysiology and treatment. Surv Ophthalmol 2013; 58(2):103-126
    21 Taban M, Boyer DS, Thomas EL, et al. Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 2004; 137(6):1073-1080
    22 Wu PC,Chen YJ,Chen CH, et al. Subthreshold transpupillary thermotherapy in Chinese patients with myopic choroidal neovascularization: one- and two-year follow up. Clin Experiment Ophthalmol 2008; 36(5):443-448
    23 Kuo HK,Kao MT,Chen YJ, et al. Transpupillary thermotherapy in chinese patients with choroidal neovascularization secondary to age-related macular degeneration: emphasis on the influence of power setting. Ophthalmologica 2008; 222(2):117-122
    24 Ozdek S,Bozan E,Gürelik G, et al. Can J Ophthalmol.Transpupillary thermotherapy for the treatment of choroidal neovascularization secondary to angioid streaks. Can J Ophthalmol 2007; 42(1):95-100
    25 Kubicka-Trzaska A1, Starzycka M, Ortyl E,et al.Transpupillary thermotherapy in exudative age-related macular degeneration. Klin Oczna 2007; 109(4-6):142-145
    26 Caminal JM,Mejia-Castillo KA,Arias L, et al. Subthreshold transpupillary thermotherapy in management of foveal subretinal fluid in small pigmented choroidal lesions. Retina 2013; 33(1):194-199
    27 Wei SY, Yang CM.Transpupillary thermotherapy in the treatment of central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging 2005; 36(5):412-415
    28 Ming Y, Algvere PV, Odergren A, et al. Subthreshold transpupillary thermotherapy reduces experimental choroidal neovascularization in the mouse without collateral damage to the neural retina. Invest Ophthalmol Vis Sci 2004; 45(6):1969-1974
    29 Sekine A,Imasawa M,Iijima H.Retinal thickness and perimetric sensitivity in central serous chorioretinopathy. Jpn J Ophthalmol 2010; 54(6):578-583
    30 Giudice GL,de Belvis V,Tavolato M,et al. Large-spot subthreshold transpupillary thermotherapy for chronic serous macular detachment. Clin Ophthalmol 2011; 5:355-360
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Qing Xiao, Jun Zeng, Luo-Sheng Tang,/et al.Transpupillary thermotherapy for central serous chorioretinopathy with parafoveal leaks. Guoji Yanke Zazhi( Int Eye Sci) 2014;14(4):755-759

Copy
Share
Article Metrics
  • Abstract:1661
  • PDF: 1262
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:December 13,2013
  • Revised:March 17,2014
  • Online: March 24,2014